RJFSA
ZYNE

Raymond James Financial Services Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Raymond James Financial Services Advisors’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$4.53K Sell
2023
Q1 		$6.11K Buy
2019
Q4 		– Sell
2019
Q3 		$117K Buy
2019
Q2 		$181K Buy